Literature DB >> 12376408

Naltrexone infusion inhibits the development of preference for a high-sucrose diet.

Allen S Levine1, Martha K Grace, James P Cleary, Charles J Billington.   

Abstract

We hypothesized that the opioid antagonist naltrexone would inhibit the redevelopment of a preference for a high-sucrose diet after an abstention period from this diet. Rats that chose between a starch or sucrose diet for 10 days preferred the sucrose diet. Rats were then given access to the starch diet alone for another 10-day period. A miniosmotic pump containing saline or naltrexone was then implanted (70 microg/h; 1.7 mg/day) for approximately 10 days. During the saline infusion, 77% of the total energy came from the sucrose diet, whereas during the naltrexone infusion, 33% of the total energy came from the sucrose diet. We repeated this study in another group of rats but did not restrict the sucrose diet. In this case naltrexone failed to decrease preference for the sucrose diet. Thus naltrexone infusion inhibited redevelopment of a preference for a sucrose diet after a period of restriction to a starch diet for 10 days but had no effect on preference if both diets were present throughout the study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376408     DOI: 10.1152/ajpregu.00040.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Alterations of naltrexone-induced conditioned place avoidance by pre-exposure to high fructose corn syrup or heroin in Sprague-Dawley rats.

Authors:  Stephen Daniels; Paul Marshall; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2015-10-30       Impact factor: 4.530

2.  Opioid mediation of starch and sugar preference in the rat.

Authors:  Kristine B Bonacchi; Karen Ackroff; Khalid Touzani; Richard J Bodnar; Anthony Sclafani
Journal:  Pharmacol Biochem Behav       Date:  2010-07-23       Impact factor: 3.533

3.  Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states.

Authors:  Elisa S Na; Michael J Morris; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2012-02-02

4.  Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.

Authors:  Dong Ji; Nicholas W Gilpin; Heather N Richardson; Catherine L Rivier; George F Koob
Journal:  Behav Pharmacol       Date:  2008-02       Impact factor: 2.293

Review 5.  The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.

Authors:  Leon P Valbrun; Valeriy Zvonarev
Journal:  J Clin Med Res       Date:  2020-02-01

6.  Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats.

Authors:  David C Jewett; Donisha S N K Liyanagamage; Mark A Vanden Avond; Molly A B Anderson; Kyleigh A Twaroski; Morgan A Marek; Kimberly F James; Tapasya Pal; Anica Klockars; Pawel K Olszewski; Allen S Levine
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

7.  Whey-Adapted versus Natural Cow's Milk Formulation: Distinctive Feeding Responses and Post-Ingestive c-Fos Expression in Laboratory Mice.

Authors:  Erin L Wood; Sarah N Gartner; Anica Klockars; Laura K McColl; David G Christian; Robin E Jervis; Colin G Prosser; Elizabeth A Carpenter; Pawel K Olszewski
Journal:  Foods       Date:  2022-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.